April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...
June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT(Positro ...
June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...
April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...
April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...
March 28, 2024 —  Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...
November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...
October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...
October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...
August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...